BetterLife Pharma Inc.
BETRF · OTC
| Reporting period ended | 1/31/2025 FY 2025 | 1/31/2024 FY 2024 | 1/31/2023 FY 2023 | 1/31/2022 FY 2022 |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $0 | $0 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $0 | $0 | $0 | $1 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $0 | $0 | $0 | $1 |
| Liabilities | – | – | – | – |
| Payables | $4 | $3 | $4 | $3 |
| Short-Term Debt | $1 | $0 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $1 | $0 |
| Other Curr. Liab. | $0 | $2 | -$3 | $4 |
| Total Curr. Liab. | $8 | $7 | $7 | $4 |
| LT Debt | $0 | $0 | $0 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | -$1 |
| Total NC Liab. | $0 | $1 | $0 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $1 | $1 | $1 |
| Total Liabilities | $8 | $8 | $8 | $5 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $80 | $78 | $77 | $75 |
| Retained Earnings | -$119 | -$115 | -$112 | -$103 |
| AOCI | $28 | $26 | $25 | $24 |
| Other Equity | $0 | -$0 | $0 | $0 |
| Total Equity | -$11 | -$11 | -$11 | -$4 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $3 | $3 | $3 | $0 |
| Total Liab. & Tot. Equity | $0 | $0 | $0 | $1 |
| Net Debt | $1 | $0 | $1 | $1 |